40T — ISEC Healthcare Income Statement
0.000.00%
Last trade - 00:00
- SG$230.23m
- SG$224.68m
- SG$69.99m
- 96
- 48
- 56
- 79
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 42.9 | 36.3 | 40.5 | 63 | 70 |
Cost of Revenue | |||||
Gross Profit | 20 | 16.1 | 17.9 | 28.8 | 31 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 32.7 | 29.4 | 31 | 45.6 | 52 |
Operating Profit | 10.2 | 6.95 | 9.5 | 17.3 | 18 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 9.9 | 6.51 | 9.09 | 16.8 | 17.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 7.25 | 4.45 | 6.88 | 12.7 | 13.2 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 7.46 | 4.69 | 6.91 | 12.5 | 13 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 7.46 | 4.69 | 6.91 | 12.5 | 13 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.016 | 0.01 | 0.012 | 0.022 | 0.023 |
Dividends per Share |